MedPath

VIRGINIA COMMONWEALTH UNIVERSITY

VIRGINIA COMMONWEALTH UNIVERSITY logo
🇺🇸United States
Ownership
Private
Established
1838-01-01
Employees
10K
Market Cap
-
Website
http://www.vcu.edu

HDAC Inhibitor Augmentation to Clozapine

Early Phase 1
Withdrawn
Conditions
Schizophrenia
Interventions
First Posted Date
2017-08-28
Last Posted Date
2024-10-15
Lead Sponsor
Virginia Commonwealth University
Registration Number
NCT03263533
Locations
🇺🇸

Virginia Commonwealth University, Richmond, Virginia, United States

Hepatitis C Virus Donor Positive Kidney Transplantation for Hepatitis C Virus Negative Recipients

Early Phase 1
Completed
Conditions
Kidney Transplant
Hepatitis C
Interventions
Drug: Direct acting Anti-Viral Therapy using Epclusa or Zepatier
First Posted Date
2017-08-15
Last Posted Date
2020-03-27
Lead Sponsor
Virginia Commonwealth University
Target Recruit Count
25
Registration Number
NCT03249194
Locations
🇺🇸

Virginia Commonwealth University, Richmond, Virginia, United States

sPLA2 in EBC During Acute Chest Syndrome

Completed
Conditions
Acute Chest Syndrome
Sickle Cell Disease
Interventions
Diagnostic Test: Exhaled Breath Condensate (EBC)
Diagnostic Test: Plasma Sample
First Posted Date
2017-08-15
Last Posted Date
2018-09-26
Lead Sponsor
Virginia Commonwealth University
Target Recruit Count
6
Registration Number
NCT03250585
Locations
🇺🇸

Virginia Commonwealth University, Richmond, Virginia, United States

In-Home Adjustment of New Spinal Cord Injury Caregivers

Not Applicable
Completed
Conditions
Spinal Cord Injuries
Interventions
Behavioral: Transition Assistance Program
First Posted Date
2017-08-09
Last Posted Date
2022-05-03
Lead Sponsor
Virginia Commonwealth University
Target Recruit Count
96
Registration Number
NCT03244098
Locations
🇺🇸

Virginia Commonwealth University, Richmond, Virginia, United States

VOR Suppression in Non-Gymnast Adults

Completed
Conditions
Vestibular
Performance
Interventions
Behavioral: VOR and coordination measurements
First Posted Date
2017-07-24
Last Posted Date
2017-10-26
Lead Sponsor
Virginia Commonwealth University
Target Recruit Count
12
Registration Number
NCT03227718
Locations
🇺🇸

Virginia Commonwealth University, Richmond, Virginia, United States

Treatment of Acute Pericarditis With Anakinra

Phase 2
Terminated
Conditions
Acute Pericarditis
Interventions
Drug: Placebo
Drug: Anakinra
First Posted Date
2017-07-21
Last Posted Date
2021-02-23
Lead Sponsor
Virginia Commonwealth University
Target Recruit Count
5
Registration Number
NCT03224585
Locations
🇺🇸

Virginia Commonwealth University, Richmond, Virginia, United States

SBRT + PD-1/PDL-1 Inhibiting Therapy for Advanced Solid Tumors After Dz Control on PD-1/PDL-1 Tx

Phase 2
Completed
Conditions
Solid Tumor
Interventions
Radiation: Stereotactic radiotherapy
First Posted Date
2017-07-18
Last Posted Date
2022-01-10
Lead Sponsor
Virginia Commonwealth University
Target Recruit Count
5
Registration Number
NCT03220854
Locations
🇺🇸

Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States

Supervised Fitness Program for Adults With Cerebral Palsy

Not Applicable
Completed
Conditions
Cerebral Palsy
Interventions
Behavioral: Fitness Center Group
Behavioral: Home Exercise Group
First Posted Date
2017-07-17
Last Posted Date
2019-08-07
Lead Sponsor
Virginia Commonwealth University
Target Recruit Count
18
Registration Number
NCT03218774
Locations
🇺🇸

Virginia Commonwealth University, Richmond, Virginia, United States

🇺🇸

Sheltering Arms, Mechanicsville, Virginia, United States

Effect of Sensory Adapted Dental Environment on Dental Anxiety of Children With Intellectual and Developmental Disabilities

Not Applicable
Completed
Conditions
Intellectual Disability
Developmental Disability
Dental Anxiety
Interventions
Behavioral: Sensory Adapted Dental Environment (SADE)
First Posted Date
2017-07-14
Last Posted Date
2018-04-18
Lead Sponsor
Virginia Commonwealth University
Target Recruit Count
22
Registration Number
NCT03218462
Locations
🇺🇸

Virginia Commonwealth University, Richmond, Virginia, United States

Examining the Effect of Mental Health Disorders on Vascular Function and Exercise Tolerance

Not Applicable
Completed
Conditions
Mental Health Disorders
Interventions
Dietary Supplement: PTSD/GAD Antioxidant
Dietary Supplement: Healthy Control Antioxidant
Dietary Supplement: PTSD/GAD Placebo
Dietary Supplement: Healthy Control Placebo
First Posted Date
2017-07-13
Last Posted Date
2021-08-25
Lead Sponsor
Virginia Commonwealth University
Target Recruit Count
40
Registration Number
NCT03216980
Locations
🇺🇸

Virginia Commonwealth University, Richmond, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath